A US randomized, 4-period crossover feeding study revealed that sodium reduction, especially when combined with a Dietary Approaches to Stop Hypertension (DASH)-style diet optimized for diabetes (DASH4D), can significantly lower blood pressure (BP) in patients with type 2 diabetes (T2D) and high BP, even among those already using multiple antihypertensive medications. From June 2021 to June 2024, there were 102 participants (85 completed all diet periods; average age 66, 66% women, and 87% Black) with T2D, systolic BP of 120–159 mm Hg, and diastolic BP under 100 mm Hg. The DASH4D diet was a modified DASH-style plan tailored for T2D patients, featuring lower carbohydrates, higher unsaturated fats, and reduced potassium compared to the original DASH diet. Participants, who were provided with all meals and maintained constant weight, followed four five-week diet periods: (1) DASH4D with lower sodium (a limit of 1,500 mg per day), (2) DASH4D with higher sodium, (3) a typical U.S. diet with lower sodium, and (4) a typical diet with higher sodium (reference). Compared with the typical high-sodium diet, the DASH4D diet with lower sodium reduced systolic BP by 4.6 mm Hg and diastolic BP by 2.3 mm Hg, with most reductions occurring within the first three weeks of each diet period. Sodium reduction had a stronger effect than the diet pattern itself, and adverse events were rare. These findings suggest that sodium reduction combined with a DASH-style diet have clinically meaningful beneficial effects. The original DASH diet is rich in fruits, vegetables, and low-fat dairy products, and low in saturated fat and cholesterol. People with T2D and high BP face a high risk of cardiovascular events related to elevated BP. Source: https://jamanetwork.com/

hyangiu

Recent Posts

Lifestyle Intervention May Slow Early Cerebral Small-Vessel Injury

A secondary MRI analysis of the US POINTER randomized clinical trial found that a structured…

9 hours ago

Shared and Region-Specific Dementia Risk Factors

Dementia risk factors vary substantially across countries, but they frequently cluster together in similar patterns…

15 hours ago

Comparative Benefits and Risks of Anti-Obesity Drugs

A systematic review and network meta-analysis of 262 randomized trials involving 99,791 participants found that…

3 days ago

Early Mild Hypertrophic Cardiomyopathy May Still Carry Significant Cardiovascular Risk

Approximately 21% of patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events…

5 days ago

High-Intensity Interval Exercise Reduces Energy Intake in Adults With Overweight or Obesity

A Danish randomized crossover trial found that a single session of high-intensity interval exercise (HIIE)…

6 days ago

Proton Pump Inhibitor and Antibiotic Use May Reduce the Benefit of Immunotherapy in NSCLC

Baseline use of proton pump inhibitors (PPIs) and, to a lesser extent, antibiotics was associated…

1 week ago

This website uses cookies.